Point Stock Analysis

PNT -  USA Stock  

USD 8.20  0.29  3.42%

Our technical analysis module allows you to check existing technical drivers of Point Biopharma Global as well as the relationship between them. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in June. However, diversifying your holdings with Point Biopharma Global or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.7. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Point Biopharma partners.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Point Biopharma stock analysis report makes it easy to digest most publicly released information about Point Biopharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Point Stock analysis module also helps to analyze the Point Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

Point Stock Analysis Notes

The company had not issued any dividends in recent years.

Point Biopharma Global Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Point Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Point Biopharma Global or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Point Biopharma generates negative expected return over the last 90 days
Point Biopharma has high historical volatility and very poor performance
Latest headline from www.equities.com: POINT Global falls 1.02 percent to Close at 8.73 on July 27 - Equities.com

Management Efficiency

Point Biopharma management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 30th of July, Point Biopharma holds the risk adjusted performance of (0.05), and Coefficient Of Variation of (1,207). Our technical analysis interface allows you to check existing technical drivers of Point Biopharma Global, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Point Biopharma Global, which can be compared to its competitors. Please check Point Biopharma Global downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Point Biopharma Global is priced some-what accurately, providing market reflects its current price of 8.2 per share. Given that Point Biopharma has jensen alpha of (0.29), we recommend you to check out Point Biopharma Global's recent market performance to make sure the company can sustain itself at a future point.

Point Biopharma Global Price Movement Analysis

The output start index for this execution was nineteen with a total number of output elements of three. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Point Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Point Biopharma Global. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Point Biopharma Global Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Point Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Point Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Point Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Point Biopharma Predictive Daily Indicators

Point Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Point Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Point Biopharma Forecast Models

Point Biopharma time-series forecasting models is one of many Point Biopharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Point Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Point Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Point Biopharma stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Point shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Point Biopharma. By using and applying Point Stock analysis, traders can create a robust methodology for identifying Point entry and exit points for their positions.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Point Biopharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module
Please check Your Equity Center. Note that the Point Biopharma Global information on this page should be used as a complementary analysis to other Point Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Point Stock analysis

When running Point Biopharma Global price analysis, check to measure Point Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Point Biopharma is operating at the current time. Most of Point Biopharma's value examination focuses on studying past and present price action to predict the probability of Point Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Point Biopharma's price. Additionally, you may evaluate how the addition of Point Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Point Biopharma Global is measured differently than its book value, which is the value of Point that is recorded on the company's balance sheet. Investors also form their own opinion of Point Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Point Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Point Biopharma's market value can be influenced by many factors that don't directly affect Point Biopharma Global underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Point Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Point Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Point Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.